Yayınlar & Eserler

Yayın Ağı
Makaleler 24
Tümü (24)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (23)
Scopus (23)
TRDizin (2)
Diğer Yayınlar (1)

1. Transforming growth factor β1 upregulates 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-4 expression in A549 and MCF-10A cells

Altunok T. H., Muchut R. J., Iglesias A. A., YALÇIN A.
Cell Biochemistry and Function , cilt.41, sa.8, ss.1220-1229, 2023 (SCI-Expanded) identifier identifier identifier

2. Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for growth of mouse embryonic stem cells that are undergoing differentiation

GÜZEL S., Gurpinar Y., Altunok T. H., YALÇIN A.
Cytotechnology , cilt.75, sa.1, ss.27-38, 2023 (SCI-Expanded) identifier identifier identifier

3. Expression of Pfkfb isoenzymes during in vitro differentiation of mouse embryonic stem cells into insulin-producing cells

GÜZEL S., YALÇIN A., Gürpinar Y., GÜLER S.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.53, sa.6, ss.1565-1573, 2023 (SCI-Expanded) identifier identifier identifier

4. Expression of dual-specificity phosphatases in TGFβ1-induced EMT in SKOV3 cells

GÜLER S., YALÇIN A.
Turkish Journal of Medical Sciences , cilt.53, sa.3, ss.640-646, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

5. Upregulation of dual-specificity phosphatase-26 is required for transforming growth factor β1(TGFβ1)-induced Epithelial-mesenchymal transition in A549 and PANC1 cells.

Guler S., Zik B., Yalcin A.
Molecular biology reports , cilt.49, sa.11, ss.10195-10204, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

6. Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor β1-induced migration and drug resistance in A549 cells in vitro

GÜLER S., Altunok T. H., Sarioglu A., ZIK B., Asmaz D., Kayapunar N., et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , cilt.606, ss.35-41, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

7. Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS transformed pancreatic cells

Ozcan S. C., Mutlu A., Altunok T. H., Gurpinar Y., Sarioglu A., GÜLER S., et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , cilt.571, ss.118-124, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

8. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells

Ozcan S. C., Sarioglu A., Altunok T. H., AKKOÇ A., GÜZEL S., GÜLER S., et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.470, sa.1-2, ss.115-129, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

9. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor beta 1-enhanced invasion of Panci cells in vitro

YALÇIN A., Solakoglu T. H., Ozcan S. C., GÜZEL S., Peker S., ÇELİKLER KASIMOĞULLARI S., et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , cilt.484, sa.3, ss.687-693, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

10. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27

YALÇIN A., Clem B. F., Imbert-Fernandez Y., Ozcan S. C., Peker S., O'Neal J., et al.
CELL DEATH & DISEASE , cilt.5, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

11. Adiponectin and Its Protective Effects

GÜZEL S., YALÇIN A.
Journal of Biological & Environmental Sciences , cilt.6, sa.17, ss.135-139, 2012 (Hakemli Dergi)

12. Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth

Telang S., Nelson K. K., Siow D. L., YALÇIN A., Thornburg J. M., Imbert-Fernandez Y., et al.
MOLECULAR CANCER , cilt.11, 2012 (SCI-Expanded) identifier identifier identifier

13. A novel small molecule antagonist of choline kinase-alpha that simultaneously suppresses MAPK and PI3K/AKT signaling

Clem B. F., Clem A. L., YALÇIN A., Goswami U., Arumugam S., Telang S., et al.
ONCOGENE , cilt.30, sa.30, ss.3370-3380, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

14. Relationship with gamma glutamyl transferase activity and glutaraldehyde coagulation test of serum immunoglobulin G concentration in newborn goat kids

YALÇIN E., TEMİZEL E. M., YALÇIN A., Carkungoz E.
SMALL RUMINANT RESEARCH , sa.1, ss.61-63, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

15. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling

YALÇIN A., Clem B., Makoni S., Clem A., Nelson K., Thornburg J., et al.
ONCOGENE , cilt.29, sa.1, ss.139-149, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

16. Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases

YALÇIN A., Clem B. F., Simmons A., Lane A., Nelson K., Clem A. L., et al.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.284, sa.36, ss.24223-24232, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

17. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer

YALÇIN A., Telang S., Clem B., Chesney J.
EXPERIMENTAL AND MOLECULAR PATHOLOGY , cilt.86, sa.3, ss.174-179, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

18. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

Clem B., Telang S., Clem A., Yalcin A., Meier J., Simmons A., et al.
MOLECULAR CANCER THERAPEUTICS , cilt.7, sa.1, ss.110-120, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

19. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase

Telang S., YALÇIN A., Clem A. L., Bucala R., Lane A. N., Eaton J. W., et al.
ONCOGENE , cilt.25, sa.55, ss.7225-7234, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

20. Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality

Chesney J., Telang S., Yalcin A., Clem A., Wallis N., Bucala R.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , cilt.331, sa.1, ss.139-146, 2005 (SCI-Expanded) identifier identifier identifier

21. Reference serum protein and lipoprotein fractions of ostriches (Struthio camelus) in Turkey

Polat U., Cetin M., Turkyilmaz O., Yalcin A.
ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH , cilt.71, sa.1, ss.77-79, 2004 (SCI-Expanded) identifier identifier identifier

22. Electrophoretic separation of urine proteins of healthy dogs and dogs with nephropathy and detection of some urine proteins of dogs using immunoblotting

Yalcin A., Cetin M.
REVUE DE MEDECINE VETERINAIRE , cilt.155, sa.2, ss.104-112, 2004 (SCI-Expanded) identifier identifier

23. Effects of dietary carnitine supplementation on plasma carnitine and some serum biochemical parameters in lambs

Cetin M., Petek M., Polat U., Yalcin A.
REVUE DE MEDECINE VETERINAIRE , cilt.154, sa.3, ss.195-198, 2003 (SCI-Expanded) identifier identifier

24. Blood biochemical parameters in fertile and repeat breeder cows

Cetin M., Dogan İ., Polat U., Yalcin A., Turkyilmaz O.
INDIAN JOURNAL OF ANIMAL SCIENCES , cilt.72, sa.10, ss.865-866, 2002 (SCI-Expanded) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 19

1. Inhibition of 6-phosphoructo-2-Kinase and Ornithine Decarboxylase Oncogenic Properties of Pancreatic Adenocarcinoma Cells.

SARIOĞLU A., GÜNEŞ N., Hazal Altınok T., YALÇIN A.
2nd International Multidisciplinary Cancer Research Congress, Giresun, Türkiye, 21 Temmuz 2022, (Özet Bildiri)

2. Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor beta 1-induced migration and drug resistance in A549 cells in vitro

GÜLER S., YALÇIN A., ZIK B.
NICHE 2022 15th National and 1st International Congress of Histology and Embryology, Türkiye, 26 Mayıs 2022, ss.28, (Özet Bildiri)

3. Studying of some regulatory mechanisms that contribute to the control of clycolysis in cancer stem cells*

gürpınar y., GÜZEL S., YALÇIN A.
2nd International Conference on “Veterinary Biochemistry and Clinical Biochemistry: Advances and Challenges in Understanding the Mechanism of Diseases, Ankara, Türkiye, 24 Ekim 2019, (Özet Bildiri)

4. Regulation of Tumor Cell Biology and Metabolism by 6-Phosphofructo-2-Kinases

YALÇIN A.
7. Multidisipliner Kanser Araştırma ve 1. Temel Onkoloji Kongresi, İzmir, Türkiye, 11 - 14 Ekim 2018, (Özet Bildiri)

5. Making insulin producing beta cells from mouseembryonic stem cells: new insight into treatment ofdiabetes mellitus

GÜZEL S., gürpınar y., ÖZCAN S. C., YALÇIN A.
I. ULUSLARARASI VETERİNER BİYOKİMYA VE KLİNİK BİYOKİMYA KONGRES, 12 Nisan 2018, (Özet Bildiri)

6. PFKFB2: Different roles of distinct splices

ÖZCAN S. C., balaban b. D., Solakoglu T. H., GÜZEL S., Chesney J. A., YALÇIN A.
ESMO Asia 2017, 17 - 19 Kasım 2017, cilt.28, (Özet Bildiri)

7. Investigation of the in vitro effects of some antibiotics on the purified Beta-glucosidases from the rat liver

YALÇIN A., Sevinc E., GÜZEL S., ÖZCAN S. C., McNally L., ŞAMLI H.
41 st FEBS Congress, 01 Eylül 2016, (Özet Bildiri) identifier

8. Silencing of PFKFB2 reduces fructose 2 6 bisphosphate levels without affecting glycolysis in KRasG12V transformed pancreatic duct cells

YALÇIN A., ÖZCAN S. C., Campbell P. M., Chesney J., GÜZEL S., Sevinç E.
New Frontiers in Understanding Tumor Metabolism, 21 - 25 Şubat 2016

9. Tümör Hücrelerinde Slug Ekspresyonunun PFKFB2 Tarafından Regülasyonu

YALÇIN A., ÖZCAN S. C., SEVİÇ E., GÜZEL S., CHESNEY J.
XXVII. ULUSAL BİYOKİMYA KONGRESİ, Türkiye, 3 - 06 Kasım 2015, cilt.40

10. Regulation of twist and slug by PFKFB2

YALÇIN A., ÖZCAN S. C., GÜZEL S., jason c.
European Cancer Congress, Vienna, Avusturya, 25 - 29 Eylül 2015, cilt.51, ss.5, (Tam Metin Bildiri)

11. A role for 6 phosphofructo 2 kinase in the epithelial mesenchymal transition of tumor cells

YALÇIN A., ÖZCAN S. C., GÜZEL S., TUĞBA HAZAL S., JASON C.
EACR-AACR-SIC Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic, Flores, Guatemala, 20 - 23 Haziran 2015, (Tam Metin Bildiri)

12. A role for 6 phosphofructo 2 kinanse in the epithelial mesenchymal transition of tumor cells

YALÇIN A., ÖZCAN S. C., GÜZEL S., Solakoğlu T. H., ŞAMLI H., Chesney J.
EACR-AACR-SIC Special conference on Anticancer Drug Action and Drug Resistance: From Cancer biology to the clinic, 20 - 23 Haziran 2015

13. PFKFB2 ve PFKFB3 Enzimlerinin Kök Hücrelerin Pluripotentliği ve Farklılaşmasındaki Rolleri

GÜZEL S., ÖZCAN S. C., BELENLİ D., GÜRPINAR Y., YALÇIN A.
VII. Veteriner ve Klinik Biyokimya Kongresi, Samsun, Türkiye, 28 - 30 Mayıs 2015

14. 6 phosphofructo 2 kinases in cellular proliferation and epithelial mesenchymal transition

YALÇIN A.
EACR-sponsored 3rd Anticancer Agent Development Congress, 18 - 19 Mayıs 2015

15. Tümör Hücrelerinde PFKFB3 Tarafından EMT Programının Regülasyonu

BELENLİ D., GÜZEL S., ÖZCAN S. C., SOLAKOĞLU T. H., YALÇIN A.
Uludağ Üniversitesi IV. Bilgilendirme ve AR-GE Günleri, Bursa, Türkiye, 11 - 13 Kasım 2014

16. Tümör hücrelerinde PFKFB2 izoformları ve lokalizasyonları

ÖZCAN S. C., BELENLİ D., GÜZEL S., MEHMET TARHAN S., YALÇIN A.
Uludağ Üniversitesi IV. Bilgilendirme ve ARGE Günleri, Bursa, Türkiye, 11 - 13 Kasım 2014

17. 6 Fosfofrukto 2 kinaz Enzimlerinin Kök Hücre Biyolojisindeki Rolü

GÜZEL S., ÖZCAN S. C., BELENLİ D., YALÇIN A.
IV. Uludağ Üniversitesi Bilgilendirme ve ARGE Günleri, Bursa, Türkiye, 11 - 13 Kasım 2014

18. Fructose 2 6 bisphosphate links glucose to survival and growth

YALÇIN A., Imbert Fernandez Y., Clem A., Oneal J., Telang S., Clem B., et al.
Metabolism, Diet, and Disease: Cancer and Metabolism, 28 - 30 Mayıs 2014, cilt.2, ss.5, (Özet Bildiri)

19. PFKFB3 EMT'de Gereklidir

YALÇIN A., ÖZCAN S. C., GÜLER S., Chesney J.
5.Multidisipliner Kanser Araştırma Kongresi, Muğla, Türkiye, 23 - 27 Nisan 2014, (Özet Bildiri)
Kitaplar 1

1. PANKREATİK DUKTAL ADENOKARSİNOMADA GLİKOLİZ VE POLİAMİN METABOLİZMASININ KOMBİNE HEDEFLENMESİ: PFKFB3 VE ODC1’İN TERAPÖTİK POTANSİYELİ

Sarıoğlu Bozkurt A., Güneş N., Yalçın A.
TEMEL VE TANISAL BİYOKİMYA, SEMA MISIR, Editör, BİDGE Yayınları, Ankara, ss.50-84, 2025 Creative Commons License
Metrikler

Yayın

52

Yayın (WoS)

24

Yayın (Scopus)

23

Atıf (WoS)

1336

H-İndeks (WoS)

12

Atıf (Scopus)

1438

H-İndeks (Scopus)

12

Atıf (Scholar)

240

H-İndeks (Scholar)

2

Proje

22

Tez Danışmanlığı

3

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları